Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

STICK IT TO COVID: Johnson & Johnson Vaccinations Available Starting November 17

Released on November 16, 2021

Saskatchewan's initial supply of 2,500 single dose Janssen (Johnson & Johnson) vaccines will be administered through a number of Saskatchewan Health Authority (SHA) clinics starting Wednesday, November 17. 

These clinics are scheduled for Regina, Saskatoon, Estevan, Prince Albert, Melfort, Swift Current, North Battleford and Lloydminster.  Note that inclement weather may delay vaccine deliveries, and additional clinic locations are planned. 

All residents are asked to check the SHA clinic location information online for the most current list of locations, dates and times before travelling.

Janssen is available to residents 18 years of age and older.  Due to the limited number of doses received and potential demand, these doses will be available on a walk-in basis at these locations only.  Janssen appointments cannot be booked online through the Patient Booking System. 

SHA clinics will be set up to permit walk-ins to be screened to receive Janssen upon request. Due to limited supply, Janssen immunizations will be based on first come, first served and available at these locations until supply is utilized. 

Fourteen days following a Janssen vaccination, you may download and present your MySaskHealth Record QR code or wallet card with required identification as proof of vaccination.

Note that Janssen is not available as a booster/third dose.  Janssen single dose vaccine recipients will be eligible for a booster dose two months following their vaccination and recipients will have an mRNA vaccine (Moderna or Pfizer) available to them.  Approved by Health Canada, it is safe to mix vaccine types and has shown to improve overall immune response to COVID-19.  

About the Janssen (Johnson & Johnson) Vaccine

Janssen (Johnson & Johnson) is a single dose, viral vector COVID-19 vaccine approved for use in Canada by Health Canada.  The recipient of Janssen vaccines are considered "fully vaccinated" 14 days after receiving their single dose.  This is the time required for the body to develop the protective immune response.

A viral vector vaccine uses a piece of a modified virus to generate an immune response but note that it is not the virus that causes COVID-19.  In the clinical trials, the Janssen vaccine had high efficacy at preventing hospitalization and death in people who did contract COVID-19. The potential side effects from receiving this vaccine are similar to all COVID-19 vaccines. 

For more information on Janssen (Johnson & Johnson), see the product information posted at

General COVID-19 Information

General public inquiries may be directed to


For more information, contact:

Phone: 306-787-4083

We need your feedback to improve Help us improve